These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 15089115)

  • 1. Residual effects of hypnotics: epidemiology and clinical implications.
    Vermeeren A
    CNS Drugs; 2004; 18(5):297-328. PubMed ID: 15089115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.
    Holm KJ; Goa KL
    Drugs; 2000 Apr; 59(4):865-89. PubMed ID: 10804040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam.
    Gustavsen I; Bramness JG; Skurtveit S; Engeland A; Neutel I; Mørland J
    Sleep Med; 2008 Dec; 9(8):818-22. PubMed ID: 18226959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hypnotic drugs on body balance and standing steadiness.
    Mets MA; Volkerts ER; Olivier B; Verster JC
    Sleep Med Rev; 2010 Aug; 14(4):259-67. PubMed ID: 20171127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative clinical profiles of triazolam versus other shorter-acting hypnotics.
    Jonas JM; Coleman BS; Sheridan AQ; Kalinske RW
    J Clin Psychiatry; 1992 Dec; 53 Suppl():19-31; discussion 32-3. PubMed ID: 1336776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical use of hypnotics: indications for use and the need for a variety of hypnotics.
    Rickels K
    Acta Psychiatr Scand Suppl; 1986; 332():132-41. PubMed ID: 2883820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review.
    Allain H; Bentué-Ferrer D; Polard E; Akwa Y; Patat A
    Drugs Aging; 2005; 22(9):749-65. PubMed ID: 16156679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring.
    Staner L; Ertlé S; Boeijinga P; Rinaudo G; Arnal MA; Muzet A; Luthringer R
    Psychopharmacology (Berl); 2005 Oct; 181(4):790-8. PubMed ID: 16025317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experience.
    Hajak G
    Drug Saf; 1999 Dec; 21(6):457-69. PubMed ID: 10612270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of short- and long-acting hypnotics in clinical medicine.
    Nicholson AN
    Br J Clin Pharmacol; 1981; 11 Suppl 1(Suppl 1):61S-69S. PubMed ID: 6133538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypnotics and actual driving performance.
    O'Hanlon JF; Volkerts ER
    Acta Psychiatr Scand Suppl; 1986; 332():95-104. PubMed ID: 3554901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sleep disorders and hypnotic agents: medical, social and economical impact].
    Touitou Y
    Ann Pharm Fr; 2007 Jul; 65(4):230-8. PubMed ID: 17652991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic.
    Wadworth AN; McTavish D
    Drugs Aging; 1993; 3(5):441-59. PubMed ID: 8241608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit-risk assessment of zaleplon in the treatment of insomnia.
    Barbera J; Shapiro C
    Drug Saf; 2005; 28(4):301-18. PubMed ID: 15783240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic.
    Goa KL; Heel RC
    Drugs; 1986 Jul; 32(1):48-65. PubMed ID: 2874974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loprazolam. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in insomnia.
    Clark BG; Jue SG; Dawson GW; Ward A
    Drugs; 1986 Jun; 31(6):500-16. PubMed ID: 2874007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of short-acting hypnotics.
    Mendelson WB; Jain B
    Drug Saf; 1995 Oct; 13(4):257-70. PubMed ID: 8573298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing short-acting hypnosedatives. Current recommendations from a safety perspective.
    Wheatley D
    Drug Saf; 1992; 7(2):106-15. PubMed ID: 1605897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New hypnotic agents: clinical studies in general practice.
    Wheatley D
    Pharmacol Biochem Behav; 1988 Apr; 29(4):811-3. PubMed ID: 3045842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zaleplon: a review of its use in the treatment of insomnia.
    Dooley M; Plosker GL
    Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.